HRTX FY 2008 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HRTXHeron Therapeutics, Inc.

$147M

FY 2008 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$369,000-10.4% YoY

Gross Profit

$369,000100.0% margin

Operating Income

-$23M-6353.7% margin

Net Income

-$23M-6266.9% margin

EPS (Diluted)

$-15.00

Cash Flow

Operating Cash Flow

-$24M

Free Cash Flow

-$25M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$12M

Total Liabilities

$4M

Stockholders' Equity

$8M

Cash & Equivalents

$10M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$369,000	$412,000	-10.4%
Gross Profit	$369,000	$412,000	-10.4%
Operating Income	-$23M	-$24M	+0.8%
Net Income	-$23M	-$20M	-14.7%